Dashboard
Manage Tickers

NVCR


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-recursion-pharmaceuticals-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Recursion Pharmaceuticals Shares Are T...
09/03/2024 17:41:09

novocures-chief-executive-officer-asaf-danziger-will-retire-at-year-end-2024-and-novocures-chief-financial-officer-ashley-cordova-will-succeed-as-the-companys-next-chief-executive-officer-effective-on-january-1-2025
Novocure's Chief Executive Officer, Asaf D...
09/03/2024 11:02:49

paypal-posts-upbeat-earnings-joins-sprouts-farmers-market-stanley-black--decker-phillips-66-and-other-big-stocks-moving-higher-on-tuesday
PayPal Posts Upbeat Earnings, Joins Sprout...
07/30/2024 14:46:55

wells-fargo-maintains-overweight-on-novocure-lowers-price-target-to-40
Wells Fargo Maintains Overweight on NovoCu...
07/26/2024 12:47:16

Wells Fargo analyst Larry Biegelsen maintains NovoCure (NASDAQ:NVCR) with a Overweight and lowers the price target from $42 ...

beyond-the-numbers-4-analysts-discuss-novocure-stock
Beyond The Numbers: 4 Analysts Discuss Nov...
07/26/2024 12:01:53

hc-wainwright--co-maintains-neutral-on-novocure-raises-price-target-to-24
HC Wainwright & Co. Maintains Neutral on N...
07/26/2024 09:54:32

HC Wainwright & Co. analyst Emily Bodnar maintains NovoCure (NASDAQ:NVCR) with a Neutral and raises the price target fro...

novocure-q2-2024-gaap-eps-031-beats-041-estimate-sales-150356m-beat-135823m-estimate
NovoCure Q2 2024 GAAP EPS $(0.31) Beats $(...
07/25/2024 11:03:12

breaking-down-novocure-4-analysts-share-their-views
Breaking Down NovoCure: 4 Analysts Share T...
07/02/2024 19:01:59

evercore-isi-group-maintains-in-line-on-novocure-raises-price-target-to-20
Evercore ISI Group Maintains In-Line on No...
07/02/2024 15:51:08

Evercore ISI Group analyst Vijay Kumar maintains NovoCure (NASDAQ:NVCR) with a In-Line and raises the price target from $14....

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
06/07/2024 17:35:20

a-closer-look-at-7-analyst-recommendations-for-novocure
A Closer Look at 7 Analyst Recommendations...
06/04/2024 13:01:00

hc-wainwright--co-reiterates-neutral-on-novocure-maintains-22-price-target
HC Wainwright & Co. Reiterates Neutral on ...
06/04/2024 10:10:50

HC Wainwright & Co. analyst Emily Bodnar reiterates NovoCure (NASDAQ:NVCR) with a Neutral and maintains $22 price target.

novocure-reports-presentation-of-clinical-data-from-phase-3-metis-trial-says-trial-met-its-primary-endpoint-demonstrating-statistically-significant-improvement-in-time-to-intracranial-progression
Novocure Reports Presentation Of Clinical ...
06/03/2024 12:02:58

Patients treated with TTFields therapy and BSC exhibited a median time to intracranial progression of 21.9 months compared to 1...

overseas-shipholding-micron-squarespace-incyte-and-other-big-stocks-moving-higher-on-monday
Overseas Shipholding, Micron, Squarespace,...
05/20/2024 15:37:53

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
05/15/2024 17:35:22

unveiling-8-analyst-insights-on-novocure
Unveiling 8 Analyst Insights On NovoCure
05/02/2024 21:01:09

hc-wainwright--co-maintains-neutral-on-novocure-lowers-price-target-to-22
HC Wainwright & Co. Maintains Neutral on N...
05/02/2024 16:41:26

HC Wainwright & Co. analyst Emily Bodnar maintains NovoCure (NASDAQ:NVCR) with a Neutral and lowers the price target fro...

novocure-secures-400m-multi-tranche-non-dilutive-debt-financing-from-pharmakon
Novocure Secures $400M Multi-Tranche Non-D...
05/02/2024 11:37:19

novocure-secures-new-400m-non-dilutive-debt-financing-from-pharmakon
Novocure Secures New $400M Non-Dilutive De...
05/02/2024 11:18:50

Use of proceeds to fund working capital needs stemming from Novocure's anticipated launch in non-small cell lung cancer and...

novocure-q1-2024-adj-eps-036-beats-042-estimate-sales-13850m-beat-13145m-estimate
NovoCure Q1 2024 Adj EPS $(0.36) Beats $(0...
05/02/2024 11:04:47

NovoCure (NASDAQ:NVCR) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.42) by 1...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION